Which prognostic indicator should we use for clinical practice in the initial evaluation and follow-up of IIP: Should we depend on PFT, HRCT or ... what?

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 22, Issue SUPPL. 1, 2005, Pages

  Caminati, Antonella ^a   Harari, Sergio ^a  

^a San Giuseppe Hospital   (Italy)

Author keywords

Idiopathic interstitial pneumonias; Non specific interstitial pneumonias; Usual interstitial pneumonias

Indexed keywords

CLINICAL PRACTICE; CONFERENCE PAPER; EVALUATION; FOLLOW UP; GAS EXCHANGE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; INTERSTITIAL PNEUMONIA; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG PARENCHYMA; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; RISK FACTOR; SURVIVAL;

BIOPSY, NEEDLE; DISEASE PROGRESSION; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG DISEASES, INTERSTITIAL; MALE; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 31544474078     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (64)

1. American Thoracic Society (ATS) and the European Respiratory Society (ERS): Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-64.
2. American Thoracic Society, European Respiratory Society: American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
3. Bjoraker JA, Ryu JH, Edwin MK, et al: Prognostic significance of histopathological subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199-203.
4. Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000; 24: 19-33.
5. Flaherty KR, Travis WD, Colby TV, et al: Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164: 1722-7.
6. Flaherty KR, Toews G, Travis WD, et al: Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002; 19: 275-83.
7. Daniil ZD, Gilchrist FC, Nicholson AG, et al: A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999; 160: 899-905.
8. Nicholson AG, Colby TV, duBois RM, Hansell DM, Wells AU: The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000; 162: 2213-17.
9. Nicholson AG, Wells AU: Nonspecific interstitial pneumonia - nobody said it's perfect. Am J Respir Crit Care Med 2001; 164: 1553-4.
10. Selman M. King TE, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001; 134: 136-51.
11. Selman M, Pardo A: Idiopathic pulmonary fibrosis: misunderstandings between epithelial cells and fibroblasts? Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 165-72.
12. Pardo A, Selman M: Idiopathic pulmonary fibrosis: new insights in its pathogenesis. Int J Biochem Cell Biology 2002; 34: 1534-8.
13. King TE, Jr., Schwarz MI, Brown K: Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001; 164: 1025-32.
14. Gay SE, Kazerooni EA, Toews GB: Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998; 157: 1063-72.
15. Flaherty KR, Colby TV, Travis WD: Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003; 167: 1410-15.
16. Flaherty KR, Colby T, Travis WD: Prognostic value of fibroblastic foci in patients with usual interstitial pneumonia. Chest 2001; 120: 76S-77S.
17. Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU: The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166: 173-7.
18. Gross TG, Hunninghake GW: Idiopathic pulmonary fibrosis. N Engl J Med 2001; 345: 517-25.
19. Hartman TE, Swensen SJ, Hansell DM, et al: Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217: 701-5.
20. MacDonald SL, Rubens MB, Hansell DM, et al: Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances and diagnostic accuracy of thin-section CT. Radiology 2001; 221: 600-5.
21. Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM: Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol 2002; 26: 1567-77.
22. Khoshnevis MR: Histopathology and prediction of survival in usual interstitial pneumonia. Am J Respir Crit Care Med 2002; 165: 1451-2.
23. Wells AU, Hansell DM, Rubens MB, Culliman P, Black CM, du Bois RM: The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993; 148: 1076-82.
24. Müller NL, Stables CA, Miller RR, Vedal S, Thurbeck WM, Ostrow DN: Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987; 165: 731-4.
25. Hunninghake GW, Zimmerman MB, Schwartz DA, et al: Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164: 193-6.
26. Raghu G: Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated for every patient? Am J Respir Crit Care Med 1995; 151: 909-14.
27. Johkoh T, Muller NL, Cartier Y, et al: Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211: 555-60.
28. Flaherty KR, Thwaite EL, Kazerooni EA, et al: Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58: 143-8.
29. Flaherty KR, Mumford JA, Murray S, et al: Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 543-8.
30. Xaubet A, Agusti C, Luburich P, et al: Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158: 431-6.
31. Akira M, Sakatani M, Ueda E: Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT. Radiology 1993; 189: 687-91.
32. Lee J, Gong G, Song K, Kim D, Lim T: Usual interstitial pneumonia: relationship between disease activity and the progression of honeycombing at thin-section computed tomography. J Thorac Imaging 1998; 13: 199-203.
33. Akira M, Yamamoto S, Hara H, Sakatani M, Ueda E: Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 1997; 52: 333-7.
34. Wells A, Rubens M, du Bois R, Hansell D: Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. Am J Roentgenol 1993; 161: 1159-65.
35. Akira M, Inoue G, Yamamoto S, Sakatani M: Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients. Thorax 2002; 55: 854-9.
36. Kim E, Lee K, Chung M, Kwon O, Kim T, Hwang J: Nonspecific interstitial pneumonia with fibrosis: serial high resolution CT findings with functional correlation. Am J Roentgenol 1999; 173: 1734-9.
37. Nishiyama O, Kondoh Y, Taniguchi H, et al: Serial high resolution CT findings in nonspecific interstitial pneumonia/fibrosis. J Comput Assist Tomogr 2000; 24: 41-6.
38. Uppaluri R, Hoffman E, Sonka M, Hartley P, Hunninghake G, McLennan G: Computed recognition of regional lung disease patterns. Am J Respir Crit Care Med 1999; 160: 648-54.
39. Uppaluri R, Hoffman E, Sonka M, Hunninghake G, McLennan G: Interstitial lung disease: a quantitative study using the adaptive multiple feature method. Am J Respir Crit Care Med 1999; 159: 519-25.
40. King TE Jr., Tooze JA, Schwarz MI, Brown KR, Cherniack RM: Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164: 1171-81.
41. Mogulkoc N, Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, Egan JJ: Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001; 164: 103-8.
42. Mogulkoc N, Brutsche MH, Bishop PW, et al: Pulmonary (99m) Tc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP). Thorax 2001; 56: 916-26.
43. Hanson D, Winterbauer RH, Kirtland SH, Wu R: Changes in pulmonary function test results after one year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest 1995; 108: 305-10.
44. Hubbard R, Johnston I, Britton J: Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. Chest 1998; 113: 396-400.
45. Mapel DW, Hunt WC, Utton R, Baumgartner KB, Samet JM, Coultas DB: Idiopathic pulmonary fibrosis: survival in population based and hospital based cohorts. Thorax 1998; 53: 469-76.
46. Erbes R, Schaber T, Loddenkemper R: Lung function tests in patients with idiopathic pulmonary fibrosis: are they helpful for predicting outcome? Chest 1997; 111: 51-7.
47. Schwartz DA, Helmers RA, Galvin JR, et al: Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: 450-4.
48. Schwartz DA, vanFossen D, Davis C, et al: Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: 444-9.
49. Fulmer J, Roberts W, vonGal E, Crystal R: Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest 1979; 63: 665-76.
50. Cherniack R, Colby T, Flint A, et al: Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151: 1180-8.
51. Solvay S, Brooks D, Lacasse Y, Thomas S: A quantitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119: 256-70.
52. Steele B: Timed walk tests of exercise capacity in chronic cardiopulmonary illness. J Cardiopulm Rehabil 1996; 16: 25-33.
53. Lama VN, Flaherty KR, Toews GB, et al: Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 1084-90.
54. Watters L, King T, Schwarz M, Waldron J, Stanford R: A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133: 97-103.
55. Watters L, Schwarz M, Cherniack R, et al: Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987; 135: 696-704.
56. Staples CA, Müller NL, Vedal S, Abboud R, Ostrow D, Miller RR: Usual interstitial pneumonia: correlation of CT with clinical, functional, and radiologic findings. Radiology 1987; 162: 377-81.
57. Wells AU, King AD, Rubens MB, et al: Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med 1997; 155: 1367-75.
58. Latsi PI, du Bois RM, Nicholson AG, et al: Fibrotic idiopathic interstitial pneumonia. The prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168: 531-7.
59. Beeh KM, Beier J, Kornmann O, et al: Neutrophilic inflammation in induced sputum of patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 138-43.
60. Wells AU, Desai SR, Rubens MB, et al: Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003; 167: 962-9.
61. Collard HR, King TE, Jr., Bucher Bartelson B, Vourlekis JS, Schwarz MI, Brown KK: Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 538-42.
62. Xaubet A, Ancochea J, Morell F, et al: Report on the incidence of interstitial lung diseases in Spain. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 64-70.
63. Lynch DA: Non specific interstitial pneumonia: evolving concepts. Radiology 2001; 221: 583-4.
64. Noble PW, Morris DG: Time will tell: predicting survival in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 510-11.